Description: Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
Home Page: www.zoetis.com
10 Sylvan Way
Parsippany,
NJ
07054
United States
Phone:
973 822 7000
Officers
| Name | Title |
|---|---|
| Ms. Kristin C. Peck | CEO & Director |
| Mr. Wetteny N. Joseph CPA | Executive VP & CFO |
| Ms. Wafaa Mamilli | EVP & Group President for China, Brazil and Preci. Animal Health |
| Dr. Robert J. Polzer Ph.D. | Executive VP and President of Research & Development |
| Mr. Keith Sarbaugh | Executive VP & Chief Digital and Technology Officer |
| Mr. Steven Frank | Vice President of Investor Relations |
| Ms. Roxanne Lagano | Executive VP, General Counsel & Corporate Secretary |
| Mr. William Price | VP & Chief Communications Officer |
| Ms. Julie A. Fuller | Executive VP, Chief Human Resources Officer & Global Operations |
| Ms. Jeannette Ferran Astorga | Executive VP of Corporate Affairs & Communications and Chief Sustainability Officer |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 27.1739 |
|---|---|
| Trailing PE: | 33.0996 |
| Price-to-Book MRQ: | 15.1611 |
| Price-to-Sales TTM: | 8.1959 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 14100 |